Acute Effects of Gastrocnemius Myofascial Release on Cervical Flexion and Extension Range of Motion in Healthy Adults

NCT ID: NCT07025746

Last Updated: 2025-06-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-06-15

Study Completion Date

2025-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to verify the immediate effects of gastrocnemius myofascial release on the active cervical flexion and extension range of motion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

After completing the questionnaire, 91 healthy participants will be randomly divided into two groups: the Intervention Group (IG) (n=46) and the Control Group (CG) (n=45). In the first assessment (M0), the range of motion of cervical flexion and extension will be measured using a smartphone (Galaxy S21 FE 5G, Android) and the Clinometer application. The myofascial release technique (foam roller) will be applied to the gastrocnemius of the dominant lower limb for 4 minutes (3 sets of 1 minute with 30 seconds of rest). Participants in the control group will remain at complete rest for a period of 4 minutes, lying in the supine position, without performing any type of active or passive intervention. Immediately after the intervention/control, all groups will be reassessed (M1).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

A myofascial release technique will be performed using a foam roller (Blackroll Standard, 30 x 15 cm) on the dominant lower limb.

For the Intervention Group (IG), the technique will be applied to the gastrocnemius muscles. In this group, participants will adopt a semi-seated position on a mat, supported by their arms while keeping the body well aligned. The movement will be performed in the direction of the muscle fibers (cephalocaudal), ensuring the accuracy of the technique.

The foam roller will be in contact with the targeted muscle, and the participant will apply pressure until experiencing slight discomfort. In this way, a self-massage will be performed following the direction of the muscle fibers.

Group Type ACTIVE_COMPARATOR

Dynamic foam rolling

Intervention Type DEVICE

The foam roller will be in contact with the muscle being tested and the patient will exert a load until they feel a slight pain. In this way, the patient performs a self-massage in the direction of the muscle fibers.

Control group

The participants will remain at rest in a chair for 4 minutes.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dynamic foam rolling

The foam roller will be in contact with the muscle being tested and the patient will exert a load until they feel a slight pain. In this way, the patient performs a self-massage in the direction of the muscle fibers.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy participants of both sexes aged 18-40 years.

Exclusion Criteria

* Deformities in the lower quadrant region of the body;
* Complaints in this region in the last 6 months;
* Surgical procedures or musculoskeletal, cardiac, renal, metabolic, neurological and or oncological pathologies;
* Limb length discrepancy greater than 1.5 cm;
* Pregnant women;
* Ingestion of non-steroidal anti-inflammatory drugs or consumption of any type of narcotic drugs and participants who have drunk alcohol in the last 12 hours.
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Fernando Pessoa

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ricardo Cardoso

Phd

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ricardo Cardoso, Phd

Role: CONTACT

+351914585064

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ESS/LFST-706/25-2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Ankle Sprains and Corticospinal Excitability
NCT00847769 COMPLETED PHASE1/PHASE2